Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: Five-year follow-up

✍ Scribed by Mr. J. M. Gilbert; K. Hellmann; Margaret Evans; P. G. Cassell; R. H. Taylor; B. Stoodley; H. Ellis; C. Wastell

• Publisher: John Wiley and Sons
• Year: 1986
• Tongue: English
• Weight: 570 KB
• Volume: 73
• Category: Article
• ISSN: 0007-1323
• DOI: 10.1002/bjs.1800730611